Glass House Brands GLAS
NYSE GLAS
$9.52 -0.18 (-1.86%)
As of: Aug 20, 2026 · 3:59 PM EDT

Glass House Brands (GLAS) Cash from Investing Activities (2020 - 2026)

Glass House Brands (GLAS) posted quarterly Cash from Investing Activities of -$2.7 million for Q1 2026, up 58.98% year-over-year from -$1.7 million in Q1 2025, and down 26.08% quarter-over-quarter from -$2.2 million in Q4 2025.

Glass House Brands (GLAS) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has reported Cash from Investing Activities for 7 consecutive years, with -$2.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 58.98% year-over-year to -$2.7 million; the TTM figure through Mar 2026 stood at -$23.8 million (down 63.14% YoY), while the FY2025 annual figure was -$27.7 million, down 169.5% from the prior year.
  • Cash from Investing Activities eased to -$2.7 million in Q1 2026 per GLAS's latest filing, from -$2.2 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $13.0 million in Q1 2022 and bottomed at -$12976.5 billion in Q4 2022.
  • Historically, Cash from Investing Activities has averaged -$1143.1 billion across 5 years, with a median of -$2.4 million in 2024.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities surged 2198.29% — and 2023, when it tumbled 19738531056.36%.
  • Glass House Brands' Cash from Investing Activities stood at -$12976.5 billion in 2022, then soared by 100.0% to $6.3 million in 2023, then slumped by 140.91% to -$2.6 million in 2024, then increased by 14.92% to -$2.2 million in 2025, then fell by 26.08% to -$2.7 million in 2026.
  • Business Quant data shows GLAS's Cash from Investing Activities at -$2.7 million in Q1 2026, -$2.2 million in Q4 2025, and -$9.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -491.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Glass House Brands 837.25 Mn 818.69 Mn 15.77 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.75 Mn
Mar 31, 2026 -2.75 Mn
Dec 31, 2025 -2.18 Mn
Dec 31, 2025 -2.18 Mn
Sep 30, 2025 -9.60 Mn
Sep 30, 2025 -9.60 Mn
Jun 30, 2025 -9.27 Mn
Jun 30, 2025 -9.27 Mn
Mar 31, 2025 -6.70 Mn
Mar 31, 2025 -6.70 Mn
Dec 31, 2024 -2.56 Mn
Dec 31, 2024 -2.56 Mn
Sep 30, 2024 -1.42 Mn
Sep 30, 2024 -1.42 Mn
Jun 30, 2024 -3.91 Mn
Jun 30, 2024 -3.91 Mn
Mar 31, 2024 -2.41 Mn
Mar 31, 2024 -2.41 Mn
Dec 31, 2023 6.26 Mn
Dec 31, 2023 6.26 Mn